[Combination of percutaneous radiotherapy, brachytherapy, and androgen deprivation equivalent alternatives to radical prostatectomy for prostate cancer]

Strahlenther Onkol. 2018 Apr;194(4):360-362. doi: 10.1007/s00066-018-1273-7.

[Article in German]

Authors

Constantinos Zamboglou¹, Anca Ligia Grosu²

Affiliations

¹ Department of Radiation Oncology Medical Center and Medical Faculty, University of Freiburg, Germany German Cancer Consortium (DKTK) Partner Site Freiburg, Freiburg, Deutschland.
² Department of Radiation Oncology Medical Center and Medical Faculty, University of Freiburg, Germany German Cancer Consortium (DKTK) Partner Site Freiburg, Freiburg, Deutschland. anca.grosu@uniklinik-freiburg.de.

PMID: 29404627
DOI: 10.1007/s00066-018-1273-7

No abstract available

Publication types

Comment

MeSH terms

Androgen Antagonists
Brachytherapy*
Humans
Male
Prostate-Specific Antigen
Prostatectomy*
Prostatic Neoplasms

Substances

Androgen Antagonists
Prostate-Specific Antigen